Canadian Online Pharmacy

CDER New June 2, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

May 30, 2014


New and Generic Drug Approvals

May 29, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Amoxil amoxicillin For Suspension;Oral Dr Reddys Labs Inc Manufacturing Change or Addition
Azilect rasagiline mesylate Tablet;Oral Teva Efficacy Supplement with Clinical Data to Support
Azilect rasagiline mesylate Tablet;Oral Teva Labeling Revision
Differin adapalene Lotion;Topical Galderma Labs Lp Manufacturing Change or Addition
Entereg alvimopan Capsule;Oral Cubist Pharms Manufacturing Change or Addition
Femring estradiol acetate Insert, Extended Release;Vaginal Warner Ireland Labeling Revision
Lovenox enoxaparin sodium Injectable;Intravenous, Subcutaneous Sanofi Aventis Us Manufacturing Change or Addition
Lovenox (Preservative Free) enoxaparin sodium Injectable;Subcutaneous Sanofi Aventis Us Manufacturing Change or Addition
Lunesta eszopiclone Tablet;Oral Sunovion Pharms Inc Manufacturing Change or Addition
Maxalt rizatriptan benzoate Tablet;Oral Merck Manufacturing Change or Addition
Maxalt-Mlt rizatriptan benzoate Tablet, Orally Disintegrating;Oral Merck Manufacturing Change or Addition
Minocin minocycline hydrochloride Capsule;Oral Precision Dermat Manufacturing Change or Addition
Mirena levonorgestrel Intrauterine Device;Intrauterine Bayer Hlthcare Manufacturing Change or Addition
Suprax cefixime For Suspension;Oral Lupin Ltd Labeling Revision
Zoledronic Acid zoledronic acid Injectable;Injection Cipla Ltd Tentative Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery